Evaluation of paraoxonase activity in patients with mixed connective tissue disease

Edit Bodolay1, Ildiko Seres, Peter Szodoray

  • 1Division of Clinical Immunology, 3rd Department of Internal Medicine, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary. bodolai@iiibel.dote.hu

The Journal of Rheumatology
|December 19, 2007
PubMed
Abstract

Insights

Patients with mixed connective tissue disease (MCTD) have reduced paraoxonase (PON) activity, increasing their risk for atherosclerosis. Lower PON levels correlate with disease severity and vascular events, highlighting its role in MCTD-related cardiovascular complications.

Area of Science:

  • Rheumatology
  • Immunology
  • Cardiovascular Medicine

Background:

  • Mixed Connective Tissue Disease (MCTD) is a systemic autoimmune disorder.
  • The relationship between inflammation and atherosclerosis in MCTD is not well-defined.
  • Paraoxonase (PON) possesses antioxidant properties and may influence cardiovascular health.

Purpose of the Study:

  • To investigate lipid profiles and PON activity in MCTD patients.
  • To explore the association between PON activity and atherosclerosis markers in MCTD.
  • To evaluate the role of PON in the pathogenesis of cardiovascular complications in MCTD.

Main Methods:

  • 37 MCTD patients and 30 healthy controls were analyzed.
  • PON activity was measured using spectrophotometry.
  • Endothelial activation markers (thrombomodulin, vWF, AECA) were quantified via ELISA.

Main Results:

  • MCTD patients exhibited significantly lower PON activity compared to controls (118.5 vs. 188.0 U/l).
  • Reduced PON activity correlated with disease duration, patient age, and history of vascular events.
  • Low PON activity was strongly associated with elevated endothelial cell activation markers.

Conclusions:

  • MCTD patients face an elevated risk of atherosclerosis.
  • Decreased PON concentration and activity are implicated in MCTD-associated atherosclerosis development.
  • PON may be a significant factor in the pathogenesis of atherosclerosis in MCTD patients.

Related Concept Videos